Zoetis Inc. (ZTS): Price and Financial Metrics

ZTS POWR Grades

• ZTS scores best on the Quality dimension, with a Quality rank ahead of 92.08% of US stocks.
• The strongest trend for ZTS is in Growth, which has been heading up over the past 26 weeks.
• ZTS ranks lowest in Momentum; there it ranks in the 27th percentile.

ZTS Stock Summary

• ZTS has a market capitalization of $88,576,804,405 -- more than approximately 97.17% of US stocks.
• The price/operating cash flow metric for ZOETIS INC is higher than 90.98% of stocks in our set with a positive cash flow.
• The volatility of ZOETIS INC's share price is greater than that of merely 8.14% US stocks with at least 200 days of trading history.
• Stocks that are quantitatively similar to ZTS, based on their financial statements, market capitalization, and price volatility, are BSX, ETN, BDX, SYK, and PBR.
• ZTS's SEC filings can be seen here. And to visit ZOETIS INC's official web site, go to www.zoetis.com.

ZTS Valuation Summary

• ZTS's price/sales ratio is 10.8; this is 157.14% higher than that of the median Healthcare stock.
• ZTS's price/sales ratio has moved up 7.1 over the prior 133 months.

Below are key valuation metrics over time for ZTS.

ZTS Growth Metrics

The 3 year net income to common stockholders growth rate now stands at 49.35%.
• Its year over year cash and equivalents growth rate is now at -12.97%.
• Its year over year net income to common stockholders growth rate is now at 16.85%.

Over the past 34 months, ZTS's revenue has gone up $1,741,000,000.

The table below shows ZTS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	8,080	1,912	2,114
2022-09-30	8,007	1,850	2,067
2022-06-30	7,995	1,977	2,090
2022-03-31	7,891	2,122	2,073
2021-12-31	7,776	2,213	2,037
2021-09-30	7,616	2,252	1,982

ZTS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ZTS has a Quality Grade of A, ranking ahead of 95.14% of graded US stocks.
• ZTS's asset turnover comes in at 0.552 -- ranking 69th of 682 Pharmaceutical Products stocks.
• UTHR, ENDP, and MYGN are the stocks whose asset turnover ratios are most correlated with ZTS.

The table below shows ZTS's key quality metrics over time.